JASPER THERAPEUTICS INC's ticker is and the CUSIP is 471871103. A total of 25 filers reported holding JASPER THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103,128 | -94.8% | 147,326 | -89.8% | 0.00% | – |
| Q2 2023 | $1,980,913 | -72.8% | 1,445,922 | -64.1% | 0.00% | -100.0% |
| Q1 2023 | $7,282,061 | +388.5% | 4,023,238 | +28.3% | 0.00% | – |
| Q4 2022 | $1,490,826 | -39.1% | 3,135,940 | +1.1% | 0.00% | -100.0% |
| Q3 2022 | $2,448,000 | -57.6% | 3,102,016 | +3.8% | 0.00% | 0.0% |
| Q2 2022 | $5,769,000 | -46.4% | 2,989,103 | -1.3% | 0.00% | -50.0% |
| Q1 2022 | $10,756,000 | -53.3% | 3,029,780 | -1.6% | 0.00% | -60.0% |
| Q4 2021 | $23,032,000 | -21.2% | 3,079,456 | +2.5% | 0.01% | -16.7% |
| Q3 2021 | $29,215,000 | – | 3,005,035 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 8,519,648 | $5,963,754 | 7.92% |
| Velan Capital Investment Management LP | 11,219,036 | $7,586,797 | 6.12% |
| Ally Bridge Group (NY) LLC | 3,144,164 | $2,200,915 | 2.58% |
| Altium Capital Management LP | 2,868,000 | $2,007,600 | 1.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 5,687,134 | $3,980,994 | 0.72% |
| Soleus Capital Management, L.P. | 8,300,980 | $5,810,686 | 0.54% |
| Octagon Capital Advisors LP | 4,468,114 | $3,127,680 | 0.48% |
| Saturn V Capital Management LP | 1,387,015 | $970,910 | 0.41% |
| Carlyle Group Inc. | 8,761,891 | $6,054,467 | 0.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 3,040,000 | $2,128,000 | 0.24% |